日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Efficacy of Engineered Toxin Body MT-3724 in Relapsed or Refractory B-cell Non-Hodgkin's Lymphomas and Diffuse Large B-cell Lymphoma

工程化毒素体MT-3724在复发或难治性B细胞非霍奇金淋巴瘤和弥漫性大B细胞淋巴瘤中的安全性和有效性

Hamlin, Paul A; Musteata, Vasile; Park, Steven I; Burnett, Christine; Dabovic, Kristina; Strack, Thomas; Williams, Eric T; Anand, Banmeet S; Higgins, Jack P; Persky, Daniel O

A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies

一项评估依沃福酰胺联合伊匹木单抗治疗晚期实体恶性肿瘤的安全性和耐受性的 I 期剂量递增研究

Hegde, Aparna; Jayaprakash, Priyamvada; Couillault, Coline A; Piha-Paul, Sarina; Karp, Daniel; Rodon, Jordi; Pant, Shubham; Fu, Siqing; Dumbrava, Ecaterina E; Yap, Timothy A; Subbiah, Vivek; Bhosale, Priya; Coarfa, Cristian; Higgins, Jack P; Williams, Eric T; Wilson, Thomas F; Lim, JoAnn; Meric-Bernstam, Funda; Sumner, Elizabeth; Zain, Hira; Nguyen, Di; Nguyen, Ly M; Rajapakshe, Kimal; Curran, Michael A; Hong, David S

Effect of a small molecule BCL-2 inhibitor on immune function and use with a recombinant vaccine.

小分子 BCL-2 抑制剂对免疫功能的影响及其与重组疫苗的联合应用

Farsaci Benedetto, Sabzevari Helen, Higgins Jack P, Di Bari Maria Giovanna, Takai Shinji, Schlom Jeffrey, Hodge James W

Vaccines based on whole recombinant Saccharomyces cerevisiae cells

基于全重组酿酒酵母细胞的疫苗

Ardiani, Andressa; Higgins, Jack P; Hodge, James W

Enhancing immune responses to tumor-associated antigens

增强对肿瘤相关抗原的免疫反应

Higgins, Jack P; Bernstein, Michael B; Hodge, James W

Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma

重组CEA-MUC-1-TRICOM痘病毒疫苗在转移性癌患者中的接种试点研究

Gulley, James L; Arlen, Philip M; Tsang, Kwong-Yok; Yokokawa, Junko; Palena, Claudia; Poole, Diane J; Remondo, Cinzia; Cereda, Vittore; Jones, Jacquin L; Pazdur, Mary P; Higgins, Jack P; Hodge, James W; Steinberg, Seth M; Kotz, Herbert; Dahut, William L; Schlom, Jeffrey